Cargando…

Assessment of Eptifibatide Dosing in Renal Impairment Before and After In-Service Education Provided by Pharmacists

BACKGROUND: Anticoagulant and antithrombotic agents are frequently cited as sources of medication errors. Several factors increase the risk of receiving excess dosing of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndrome (ACS), including older age, female gender, elevated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donovan, Jennifer L., Schroeder, Walter S., Tran, Maichi T., Foster, Keith, Forrest, Alan, Lee, Tamara B., Gandhi, Pritesh J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2007
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437991/ https://www.ncbi.nlm.nih.gov/pubmed/17874866 http://dx.doi.org/10.18553/jmcp.2007.13.7.598

Ejemplares similares

Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study
por: Luo, Long, et al.
Publicado: (2022)

Pharmacists as accessible health care providers: quantifying the opportunity
por: Valliant, Samantha N, et al.
Publicado: (2022)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

A Systematic Approach to Providing COVID-19 Vaccinations in the Community by Student Pharmacists
por: Luli, Alex J., et al.
Publicado: (2022)

RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
por: Bardania, Hassan, et al.
Publicado: (2019)

Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Jalalian, Rozita, et al.
Publicado: (2023)

Development of a Unique Student Pharmacist Internship in a Primary Care Provider System
por: Fenn, Norman E., et al.
Publicado: (2019)

Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion
por: Bertuglia, Silva, et al.
Publicado: (2002)

Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction
por: Hamza, Mohamed A., et al.
Publicado: (2014)

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
por: Boettcher, Brent T., et al.
Publicado: (2016)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis
por: Rana, Ameena, et al.
Publicado: (2022)

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice
por: Tonin, Gašper, et al.
Publicado: (2023)

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)

Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study
por: Via-Sosa, M Angeles, et al.
Publicado: (2013)

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy
por: Lankford, Cory, et al.
Publicado: (2021)

Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient
por: Alipour-Parsa, Saeed, et al.
Publicado: (2016)

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms
por: Bavand Savadkouhi, Maryam, et al.
Publicado: (2017)

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction
por: Shemirani, Hasan, et al.
Publicado: (2019)

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease
por: Ma, Yunsheng, et al.
Publicado: (2010)

Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells
por: Pathak, Alokkumar, et al.
Publicado: (2008)

Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
por: Ryan, Grace, et al.
Publicado: (2020)

Drug Use Evaluation of Sitagliptin Dosing by Pharmacist Versus Nonpharmacist Clinicians in an Internal Medicine Department of a Private Physician-Owned Multispecialty Clinic
por: McFarland, M. Shawn, et al.
Publicado: (2009)

Perceptions and experiences of promotoras and pharmacists in an academic-community partnership providing telephonic MTM services to a Spanish-speaking, rural population: a focus group study
por: Guerra, Blanca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_osclvnnm5kjefaolam8rcua48f